Hutchison MediPharma Founder And CEO Samantha Du On China's Drug R&D Ecosystem: An Interview With PharmAsia News
This article was originally published in PharmAsia News
Executive Summary
Among the first wave of returnees back to China, Samantha Du, who conducted global licensing for metabolic diseases with Pfizer, and cofounded Hutchison Chi-Med., returned to Shanghai to start biotech company Hutchison MediPharma in 2002